AstraZeneca has become the latest big pharma to jump on the artificial intelligence R&D bandwagon, penning a deal with the UK’s BenevolentAI to find new kidney and lung drugs.<
The UK government has handed out a further tranche of cash to digital health projects exploring artificial intelligence, machine learning, and hand-held devices.
Eleven years is a long time to be writing about ‘digital pharma’, and I do indeed remember when it was all My First Twitter Account and iPhone Apps as far as the eye could see.
Israel’s Zebra Medical Vision has announced that two imaging analytics products have been granted CE certification in Europe, to accelerate review and diagnosis of acute conditions in medic